Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c] quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring

被引:28
作者
Calabri, FR
Colotta, V
Catarzi, D
Varano, F
Lenzi, O
Filacchioni, G
Costagli, C
Galli, A
机构
[1] Univ Florence, Dipartimento Sci Farmaceut, I-50019 Sesto Fiorentino, FI, Italy
[2] Univ Florence, Dipartimento Farmacol Preclin & Clin, I-50134 Florence, Italy
关键词
oxazoloquinoline derivatives; ionotropic glutamate receptor antagonists; glycine/NMDA receptor antagonists; AMPA receptor antagonists;
D O I
10.1016/j.ejmech.2005.03.017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and biological evaluation at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives are reported. Different substituents were introduced at the 2-position (mercapto, carbonyl and methyl groups) and on the fused benzo ring (chlorine atom(s) and trifluoromethyt group). Among the herein reported compounds, the 2-mercapto-derivatives 1-4 showed the highest Gly/NMDA affinities, comparable to that of 5,7-dichlorokynurenic acid. The most active compound was the 7-chloro-substituted derivative I (K-i = 0.082 mu M) which possesses a Gly/NMDA selectivity of 50- and 500-fold with respect to AMPA and KA receptors, respectively. Functional antagonism studies performed on some selected 2-mercapto compounds, at both AMPA and NMDA receptor-ion channels, assessed the antagonistic properties of these derivatives. SAR studies pointed out the importance of the concurrent presence of electron-rich moieties at both the 2- and 3-positions of the oxazolo[4,5-c]quinolin-4-one framework. In fact, the 3-sp(2)-nitrogen atom plays a significant role in reinforcing the hydrogen bond that the 4-carbonyl oxygen probably forms with the arginine residue (R523) of the Gly/NMDA receptor site. The presence of 2-substituent able to form a hydrogen bonding interaction was also proved to be important for a good Gly/NMDA receptor affinity. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:897 / 907
页数:11
相关论文
共 36 条
[1]  
ASANO J, 2001, Patent No. 2001046190
[2]   Selectivity fields: Comparative molecular field analysis (CoMFA) of the glycine/NMDA and AMPA receptors [J].
Baskin, II ;
Tikhonova, IG ;
Palyulin, VA ;
Zefirov, NS .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (19) :4063-4069
[3]   AMPA receptor agonists, antagonists and modulators: their potential for clinical utility [J].
Bigge, CF ;
Nikam, SS .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (10) :1099-1114
[4]   Glutamate and the glutamate receptor system:: a target for drug action [J].
Bleich, S ;
Römer, K ;
Wiltfang, J ;
Kornhuber, J .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 :S33-S40
[5]   Ligands for glutamate receptors:: Design and therapeutic prospects [J].
Bräuner-Osborne, H ;
Egebjerg, J ;
Nielsen, EO ;
Madsen, U ;
Krogsgaard-Larsen, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2609-2645
[6]   Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: Novel and highly potent antagonists for NMDA receptor glycine site [J].
Cai, SX ;
Zhou, ZL ;
Huang, JC ;
Whittemore, ER ;
Egbuwoku, ZO ;
Lu, YX ;
Hawkinson, JE ;
Woodward, RM ;
Weber, E ;
Keana, JFW .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (17) :3248-3255
[7]   Structure -activity relationships of 4-hydroxy-3-nitroquinolin-2(1H)-ones as novel antagonists at the glycine site of N-methyl-D-aspartate receptors [J].
Cai, SX ;
Zhou, ZL ;
Huang, JC ;
Whittemore, ER ;
Egbuwoku, ZO ;
Hawkinson, JE ;
Woodward, RM ;
Weber, E ;
Keana, JFW .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (23) :4682-4686
[8]   4,5-dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones:: Excitatory amino acid antagonists with combined glycine NMDA and AMPA receptor affinity [J].
Catarzi, D ;
Colotta, V ;
Varano, F ;
Cecchi, L ;
Filacchioni, G ;
Galli, A ;
Costagli, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (13) :2478-2484
[9]   Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4-oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists [J].
Catarzi, D ;
Colotta, V ;
Varano, F ;
Calabri, FR ;
Filacchioni, G ;
Galli, A ;
Costagli, C ;
Carlà, V .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) :262-272
[10]   7-chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates as novel highly selective AMPA receptor antagonists [J].
Catarzi, D ;
Colotta, V ;
Varano, F ;
Cecchi, L ;
Filacchioni, G ;
Galli, A ;
Costagli, C ;
Carlà, V .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (21) :3824-3826